Cannon Gillian sold XENE
June 5, 2026 · Form 4 insider transaction
Cannon Gillian sold 1,190 shares of Xenon Pharmaceuticals Inc. at $53.14 per share, a transaction worth $63.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,190
Price
$53.14
Total value
$63.2K
InsiderCannon Gillian
RoleDirector
SecurityCommon Shares
Transaction codeS: Open-market sale
Transaction dateJune 5, 2026
Filing dateJune 8, 2026
Shares owned after1,455
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on August 15, 2025, solely to satisfy income tax obligations related to the vesting of RSUs granted on June 5, 2025.